Josephine Savard
Stockholm, Stockholm County, 171 76, Sweden
Location status: Recruiting
NCT Number: NCT05861752
The goal of this case-control study is to compare clinical characteristics in help-seeking individuals with paraphilic disorders or sexsomnia (sexual behaviors during sleep- a diagnosis in the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-5)), as compared to healthy controls. The main questions this study aims to answer are:
(1a) Is there a difference in experience of violence between the clinical population and healthy controls? Is there a difference between the clinical groups?
(1b) What are the clinical characteristics of these conditions (psychiatric, sociodemographic, and genetic/epigenetic factors)? Does the clinical population differ from healthy controls?
(1c) How are the psychometric properties of the assessment forms (primarily those addressing sexual deviance and compulsive sexuality) in the project?
(1d) How has sexual interest developed over time among patients with paraphilic disorders? (including the person's own description of e.g. triggers and expectations).
Follow-up of clinical population:
(2) What is the typical treatment as usual (TAU) for the patient population? (e.g., average length of care, the percentage of dropouts and what kind of treatment has been given) (3) Are there any factors at baseline (e.g., presence of neuropsychiatric symptoms, age, symptom burden) that predict treatment outcome? (i.e., symptom burden based on self-assessments at follow-up 3, 6 and 12 months from the start of treatment and records in offence registers after 10 years).
Interested in participating?
Request Info18 year and older
All sexes
Observational
Stockholm, Stockholm County, 171 76, Sweden
Location status: Recruiting
After obtaining a written consent, a physician conducts a structured medical assessment including assessment of psychiatric co-morbidity and medical history.
The participant will thereafter answer questions about socio-demographic factors, sexual preference and relational status and answer questionnaires (see last section). Scales that address sleep are used on indication.
Continued assessment includes a structured evaluation of psychiatric symptoms according to DSM-5 criteria, as well as a psychological assessment focused on the individual's sexual behaviour.
The person will also undergo computerized neuropsychological testing of impulsivity and, if consent has been given, also provide a blood samples.
After the assessment phase (intake) we will evaluate psychiatric diagnoses and make a treatment plan.
To answer question 1d (progress description), we will conduct qualitative interviews with 20 persons with sexual deviations. Those participating in this qualitative interview will provide written consent. The interview will take approximately 60 minutes, will be recorded, transcribed, and analyzed qualitatively.
To answer questions 2 and 3, we will after 3, 6 and 12 months note the type of treatment being given (e.g., Cognitive behavioral therapy or pharmacological), the number of completed visits and the number of interrupted treatments.
Treatment is also followed up with questionnaires.
Questionnaires/assessments used in the project:
The Achenbach System of Empirically Based Assessment (ASEBA)
Personality Inventory for DSM-5 (PID-5)
Montgomery Åsberg Depression Rating Scale (MADRS-S)
Ritvo Autism and Asperger Diagnostic Scale - Screening Tool (RAADS-14).
The Adult ADHD Self-Report Scale - Screen (ASRS-v1.1 Part A).
The Alcohol Use Disorders Identification Test (AUDIT)
The Drug Use Disorders Identification Test (DUDIT).
Childhood Trauma Questionnaire - Short Form (CTQ-SF)
Barratt Impulsiveness Scale (BIS).
The Brief version of the Difficulties in emotional regulation scale (DERS-16)
Brunnsviken Brief Quality of Life Inventory (BBQ)
Revised University of California (UCLA) Loneliness Scale (RULS)
Perceived Social Support (PSS-14)
Perceived Stress Scale (PSS)
Karolinska Interpersonal Violence Scale (KIVS)
Hypersexual Disorder Current assessment scale (HD:CAS)
Compulsive sexual behavior disorder scale (CSBD-19)
Rape scale
Hypersexual Behavior Inventory (HBI)
Client Satisfaction Questionnaire (CSQ-8)
Susceptibility to Temptation Scale (STS)
Långström Self-assessment of Sexual Interests (LASSIE)
Insomnia Severity Index (ISI)
Karolinska sleep questionnaire (KSQ)
Frotteuristic Disorder: Current Assessment Scale (FD: CAS) Voyeuristic Disorder: Current Assessment Scale (VD: CAS) Exhibitionistic Disorder: Current Assessment Scale (ED: CAS) Coercive Sexual Sadism Disorder: Current Assessment Scale (CSSD: CAS)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Criteria for control persons:
Inclusion criteria
Exclusion criteria
both groups will undergo a psychiatric assessment including interviews, impulsivity tests and fill out questionnaires and leave blood samples. The clinical population will be followed regarding treatment as usual
Time frame: Baseline
the outcome measure for main question (1a) is the Karolinska interpersonal violence scale (KIVS) that measures exposure to and use of violence. The Karolinska Interpersonal Violence Scale contains 4 rating scales assessing exposure to violence and expressed violent behavior in childhood (between 6-14 years of age) and during adult life (15 years or older). The subscales are scored 0-5. (Min = 0, Max= 20). Higher scores indicate more experience of violence.
Time frame: Baseline
A psychiatric assessment will be conducted using a semi-structured clinical interview routinely applied at the ANOVA clinic. The interview is performed by a specialist in psychiatry and is based on established clinical practice.
The assessment covers psychiatric history, current symptoms, functional impairment, and relevant psychosocial factors.
Clinical diagnoses will be established according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Diagnostic conclusions are based on the clinician's overall evaluation, integrating information from the interview and, when applicable, additional clinical data.
Time frame: At baseline.
A self-assessment scale based on the diagnostic criteria for paraphilic disorders listed in Screening for paraphilic disorders in the DSM-5
Time frame: At baseline.
is a self-assessment of personality-related traits and problems in different domains.
Time frame: At baseline.
a self-report questionnaire for adults screening for e.g., behavioural problems. Each item is not directly correlated with a specific scale, instead the assessments recognize patterns of syndromes.
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Symptoms of hypersexual disorder. Score range is 0-24. A higher score indicates more severe problems.
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Score range is 0-54. A higher score indicates more severe problems.
Time frame: At baseline.
Score range is 30-120. A higher score indicates more severe problems.
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Score range is 19-76. A higher score indicates more severe problems.
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Assessment of cognitive distortions about sex. Score range is 36-144. A higher score indicates more severe problems.
Time frame: At baseline.
Score range is 11-55. A higher score indicates more severe problems.
Time frame: At baseline, and after 3, 6 and 12 months for each individual with sexsomnia.
Score range is 0-28. A higher score indicates more severe problems.
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Score range is 16-80. A higher score indicates more severe problems.
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Score range is 0-48. A higher score indicates high quality of life
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Score range is 8-32. A higher score indicates higher treatment satisfaction
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Score range is 20-80. A higher score indicates more loneliness.
Time frame: At baseline, and after 3, 6 and 12 months for each individual with sexsomnia.
Score range is 13-65. A higher score indicates more severe problems.
Time frame: Collected at baseline.
Whole blood (DNA-preparation): investigation of NR3C1, NR3C1, FKBP5, CRHR1, CRHR2, LHB, GNRHR, OXTR, CD38, OPRM1, OPRD1, OPRK1, and epigenetic age.
Time frame: At baseline,and after 3, 6 and 12 months for each individual.
a 19-item scale constructed to reflect the proposed DSM-5 criteria of hypersexual disorder. Score range is 19-95. A higher score indicates more severe problems.
Time frame: At baseline.
Total score range 0-40, ≥ 8 indicates harmful use.
Time frame: At baseline.
Total score range 0-44, ≥ 6 indicates harmful use.
Time frame: At baseline.
Consists of 28 items and measures different aspects of childhood abuse and neglect, each with 5 items. Subscale score range: 5-25. A score above 5 indicate experience of trauma/neglect.
Time frame: At baseline.
From CANTAB® [Cognitive assessment software]. Cambridge Gambling Task (CGT) Stop Signal Task (SST)
Time frame: At baseline, and after 3, 6 and 12 months for each individual.
Two subscales, one addressing support from family and the other from friends. Score range is 20-80. A higher score indicates more severe problems.
Time frame: At baseline.
A self-report screening scale of adult attention-deficit/hyperactivity disorder (ADHD) consisting of 18 questions about symptoms of adult ADHD. Each item is rated on a 5-point Likert scale with 0="never" and 4="very often". Part A (items 1-6) has four items of inattention and two items of hyperactivity/impulsivity, and could be used for screening
Time frame: At baseline.
The scale consists of 14 items and total score range from 0 to 42. A score of 14 indicate need for further assessment.
Time frame: At baseline and after 3, 6 and 12 months for each individual. (For research question 1c: within 6 years)
The questionnaires are all scored 0-32. A higher score indicates more severe problems.
Time frame: within 6 years
A 60 min interview focusing on the disorder progress from first memory to current state.
Time frame: Registration at baseline and after 3, 6 and 12 months for each individual
Registration if the participant is receiving cognitive behavioral therapy, pharmacological, psychoeducation, number of fulfilled treatments, average treatment duration.
Time frame: At baseline (part of clinical evaluation)
Age, education level, country of origin, gender identity, relationship status, residence, living condition, offspring, employment, sexual orientation, medical treatment
Time frame: After 10 years
Convictions in the Swedish offence register
Contact information is provided by the study sponsor or research team.
Region Stockholm
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06404684
Mental Disorders, Paraphilic Disorders
Stockholm, Stockholm County, Sweden
View Trial DetailsNCT04633668
Mental Disorders, Nervous System Diseases
Winnipeg, Manitoba, Canada
View Trial DetailsNCT02037438
Chronobiology Disorders, Circadian Rhythm Sleep Disorder
Redwood City, California, United States
View Trial DetailsNCT07414680
Aging, Behavior
Taipei, Taiwan
View Trial Details